Lumida
/BBUC
⌘K
Brookfield Business Corp

Brookfield Business Corp

BBUC
$26.41USD+0.11%+0.03 today

MARKET CAP

5.4B

P/E (TTM)

FWD P/E

DAY RANGE

$26 – $27

52W RANGE

$26
$38

AI Summary

Stalk
TrimMedium

BBUC maintains a clear downtrend with sequential lower highs and lows; medium-term bias is bearish reinforced by a bearish EMA stack; short-term conditions are extreme oversold yet extended below declining EMAs, so optimal sell entries will come on a relief bounce into the 9- and 20-day EMAs.

  • Clarios stake seen doubling over five years supported by $1B cash tax credits
  • Generated $2B from asset recycling, repaid $1B debt, boosting liquidity for deals
  • Negative earnings yield and low profitability factors highlight margin pressure
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Brookfield Business Corporation (BBUC) is a leading alternative asset manager affiliated with Brookfield Asset Management, focusing on diverse sectors including real estate, renewable power, infrastructure, and private equity. With a strong emphasis on capital recycling and operational efficiency, BBUC positions itself to drive long-term value creation, particularly in high-demand markets for critical minerals and AI technology deployment. The firm aims to leverage its vast industry expertise and diversified portfolio to enhance its operational capabilities and increase shareholder value over time.

Bull says

  • Clarios stake seen doubling over five years supported by $1B cash tax credits
  • Generated $2B from asset recycling, repaid $1B debt, boosting liquidity for deals
  • Repurchased $300M of stock at ~50% NAV discount, enhancing shareholder value
  • Acquired World Freight and Gregg Distributors to accelerate revenue and margins
  • Invested $500M in AI (OpenAI DeployCo) to drive productivity gains
  • Q2 EBITDA $587M and EFO $289M with $2.8B pro-forma liquidity

Bear says

  • Negative earnings yield and low profitability factors highlight margin pressure
  • Analysts slashed earnings forecasts, raising downside revision risk
  • High share volatility could amplify losses during market stress
  • Low liquidity may impede trade execution and intensify price swings
  • Integration risks from recent acquisitions could erode projected synergies
  • Geopolitical and macroeconomic uncertainty may pressure industrial and service segments

Earnings Call · Q2 2024 · Mgmt. Guidance

Updated 08-14-2026neutral

Transcript signals

Bull points

  • While this continues, we do see signs that it is stabilizing. However, we remain cautious. The US has been very resilient. GDP expectations for the second half of the year have stabilized. Unemployment remains low, and consumer sentiment has inched higher in the past few months.
  • Most importantly, we're not standing still. We have continued to make significant progress in our value creation plans across the business. As a result, we've been able to maintain, and in some cases increase, margins in more difficult near-term environments while continuing to strengthen the long-term positioning of our businesses.
  • For example, at Dexco, while volumes have contracted, margins have increased approximately 200 basis points since our acquisition due to the phenomenal job the business has done to right size its cost structure, strengthen its market position, and optimize productivity.

Bear points

  • overall industry growth has been a bit slower than we expected.
  • Pricing continues to be a bit challenging in the market, given some demand challenges and volume softness.
  • overall industry growth has been a bit slower than we expected.
Read full transcript analysis ›